Search

Competing Interests: I have campaigned and published on the need to reduce bias and improve transparency in health research (www.improvehealthresearch.com).

Competing Interests: Competing interests: SHB is clinical lead for cancer for the Leeds office of the West Yorkshire Integrated Care Board.

Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and have the following interests to declare: SHB is clinical lead for cancer for Leeds Office of West Yorkshire Integrated Care Board. In this role he has supported a scheme to facilitate community pharmacists to advise patients with common respiratory symptoms to have a chest x ray. During 2017-21 he was an executive committee member of the Fabian Society, a political think tank affiliated to the UK Labour party. In this role he co-edited a series of essays on health inequalities, the publication costs of which were paid for by the Association of the British Pharmaceutical Industry and Lloyd’s pharmacies. WTH sits on a primary care advisory group for NHS England and has advised on the current pilot of pharmacy cancer detection. He is a co-applicant on an NIHR funded study aiming to optimise colorectal cancer detection through pharmacies. All authors are writing in a personal capacity, and opinions expressed here should not be considered to represent the views of any organisation to which the authors have an affiliation. Provenance and peer review: Not commissioned; externally peer reviewed.

Competing Interests: Competing interests: SHB is the clinical lead for cancer for the Leeds Office of West Yorkshire Integrated Care Board and has received funding from the National Institute for Health and Care Research and Cancer Research UK for research on cancer diagnosis. IF has received funding from the National Institute for Health and Care Research (School for Primary Care Research) for research on cancer diagnostic capacity.

Competing Interests: Competing interests: SHB and MM have advocated for reformed research and publication practices, including that journals permit authors to publish using the Registered Reports format. SHB has had work published and rejected by The BMJ. SHB has on occasion been baffled by The BMJ’s editorial decisions.

Competing Interests: Competing interests: I am the clinical lead for cancer for the Leeds office of the West Yorkshire Integrated Care Board. My employment at the University of Leeds is supported by funding from the National Institute for Health and Care Research. I have previously served on a funding committee for the National Institute for Health and Care Research. I previously served on the executive committee of a political think tank affiliated to the UK Labour Party (the Fabian Society), as part of this role I co-edited a series of essays, the publication costs of which were funded by the Association of the British Pharmaceutical Industry and Lloyds Pharmacy. The views presented are those of the author alone and do not reflect those of employers or any affiliated organisations.

Competing Interests: Competing interests: I am a researcher in cancer diagnosis and have received funding for doctoral research from Cancer Research UK. I am the clinical lead for cancer for the Leeds office of the West Yorkshire Integrated Care Board.

Competing Interests: Competing interests: I have advocated for improvements in transparency and quality of medical research (www.ImproveHealthResearch.com). I have received support from the McCall MacBain foundation to attend the EBMLive conference in 2019 and 2022. My own record of data sharing for studies I have published is suboptimal. I am clinical lead for cancer for the Leeds office of the West Yorkshire Integrated Care Board. Full information on interests is available: https://medicinehealth.leeds.ac.uk/medicine/staff/1211/dr-stephen-bradley

Competing Interests: Competing interests: SB receives funding for doctoral research from the CanTest collaborative (Cancer Research UK) and is employed as clinical lead for cancer for NHS Leeds clinical commissioning group. The publication costs of a collection of essays on health inequalities which he co-edited for the Fabian Society was funded by the Association of the British Pharmaceutical Industry and Lloyds Pharmacies, but he received no direct funding or payment for this.

Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and declare that SHB receives funding for doctoral research from the CanTest collaborative (Cancer Research UK) and is employed as clinical lead for cancer for NHS Leeds clinical commissioning group. The publication costs of a collection of essays on health inequalities which he co-edited for the Fabian Society (a political think tank) was funded by the Association of the British Pharmaceutical Industry and Lloyds Pharmacies, but he received no direct funding or payment for this.

Competing Interests: Provenance and peer review: Not commissioned; externally peer reviewed.

Competing Interests: Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: SHB receives funding from Cancer Research UK (CanTest collaborative, [C8640/A23385]) for doctoral research on cancer diagnosis and serves on the executive committee of the Fabian Society, which is a think tank affiliated to the Labour Party. A full statement of interests for SHB is available at https://medicinehealth.leeds.ac.uk/medicine/staff/1211/dr-stephen-bradley. MEB carries out epidemiological and health services research to support earlier diagnosis of cancer but is not involved with research into biomarker tests. He has no other interests to declare. The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.

Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and declare the following interests: SHB is a member of the executive committee of the Fabian Society, which is a political think tank affiliated to the Labour Party, and is undertaking a PhD which is funded by Cancer Research UK. PW has received travel expenses and fees from IQVIA World Publications patient and public participation work. EK has no competing interests to declare.